TD Cowen reinitiated coverage on Tempus AI Inc (NASDAQ:TEM) with a Buy rating, increasing the price target to $74 from a previous target. The stock, currently trading at $61.85, has shown remarkable ...

Ageing backwards is a desire many nurture. For millionaire entrepreneur and founder of Blueprint, Bryan Johnson, it’s an ...

While genetic testing rates for advanced ovarian cancer have increased, gaps in physician understanding and confidence in ...

A set of Colorado Senators are demanding extra oversight of the Colorado Bureau of Investigation after discoveries of 500-day ...

We recently published a list of Top 10 AI Stocks Trending On Wall Street. In this article, we are going to take a look at where Tempus AI, Inc.

Pharmacogenomics - tailoring drug treatments to individuals based on their genetics - is on the cusp of transforming drug ...

The VA Medical Center in North Las Vegas says they are the first hospital in the region to offer a new kind of testing.

The San Jose Police Department is hoping to generate new leads in sexual assault cold cases by resubmitting hundreds of rape ...

A new round of genetic seafood testing conducted for a state advisory panel detected foreign shrimp that was falsely ...

Shares of Calvin Klein-owner PVH Corp and genetic testing company Illumina fell on Tuesday after China placed the two ...

Looks like Finn Finnegan is all set to play fire and it could ruin his relationship with Steffy, reveal The Bold and The ...

Learn about hereditary cancer and how it can be passed down through generations. Understand the role of genes and DNA in ...